$HIPH- #CBD and revenue! $HIPH sales up 1.134% per last

New Post Public Reply Private Reply Replies (0) Message Board
stockstein
589
$HIPH- #CBD and revenue! $HIPH sales up 1.134% per last Press Release a few days ago & OTCmarkets.com filings!!! $HIPH has #CBD infused hydrogen water product via its LALPINA brand (no other #CBD/Hydrogen in mkt)

64 million verified issued/outstanding shares

$HIPH's newly acquired subsidiary GENTS, www.gentsco.com has added significant revenue and products are sold in Bloomingdale's, Saks and Nordstrom

$HIPH #undervalued at current share price in my opinion. Wont be shocked to see $HIPH at 10cent per share in near future

*link below a must read on #CBD market and $HIPH
http://emerginggrowth.com/company-may-become-...-retailer/

Scroll down for more posts ▼

Top 10 Most Recent News Articles

D-Wave Investors Face Pressure Ahead of December 15

Updated Category News Views 3

Investors Eye December 15 Deadline Nothing like a looming deadline to stir up some anxiety among investors, and that's exactly what's going down at D-Wave Quantum Inc. right now. We're talking about the class action lawsuit spearheaded by the firm Robbins Geller Rudman & Dowd LLP. They've sent out a call to arms for investors who suffered significant losses from February...

Continue Reading
Qingdao's Food Trade Triumph at SIAL Paris Booms

Updated Category News Views 3

Qingdao Impresses in the Global Food Arena Well, 2026 is serving up something special from Qingdao. During SIAL Paris, everyone's talking about how Qingdao’s food companies smashed expectations with 82 million yuan in intended orders. You’ve got CCPIT Qingdao pulling the strings, setting up an exhibition platform that was nothing short of top-tier. Staging a Show at...

Continue Reading
Electrolux Trends: Q3 '26 Shows Resilience Amid Challenges

Updated Category News Views 3

Electrolux's Strategic Moves In A Tough Market Electrolux's Q3 2026 paints a gritty picture—yet there's a pulse of resilience underneath the numbers. Net sales bumped up to SEK 33,919m due to a 3.5% organic growth, showing the company's ability to swim through choppy waters. But let's not brush aside the sharp rocks they’re dodging: soaring raw materials and logistics...

Continue Reading
TORL Bio's Ixo-V Drug Shows Promise in Combatting GCT

Updated Category News Views 2

A Beacon of Hope in Germ Cell Tumor Treatment There's something brewing in the oncology world that's worth a nod. TORL BioTherapeutics has rolled out some interesting preliminary data for their hopeful cancer buster, ixotatug vedotin, or Ixo-V. This study is part of a wider effort to take a swing at recurrent germ cell tumors (GCTs) with some tough results already making...

Continue Reading
Innventure Faces Chaotic Legal Storm Over DarkNX Scandal

Updated Category News Views 1

Innventure's DarkNX Project: From Boon to Bane The stock market is no stranger to seismic shifts, but Innventure, Inc.'s recent plunge is a testament to the catastrophic impact missteps can unleash. This whole DarkNX debacle feels more like a meticulous car wreck than a business evolution. Unpacking the Allegations Sitting comfortably under the NASDAQ:INV ticker,...

Continue Reading
Lowcountry Kids to Get Free Helmets at Safety Events

Updated Category News Views 1

Helmets for Kids Initiative Gets Rolling Now, here's a story that's more about community care than cash flow, but hey, sometimes even a grizzled trader like me can nod in appreciation. Christmas Injury Lawyers are putting their money where their mouth is, with the Helmets for Kids initiative staged at two key events in the Lowcountry area. Yep, that's right—the legal...

Continue Reading
ImmunoForge Sets Sights on BIO-Europe 2026 for New Deals

Updated Category News Views 3

Making Waves with Cutting-Edge Drug Platforms Ah, how time flies in the biotech universe. Here we are, with ImmunoForge prepping to flaunt its high-tech gear at the big show in Cologne: BIO-Europe 2026. The company's aiming to gauge attention with its flashy ELP and LMT platforms, primed and ready for strategic partnerships. ELP: Revolutionizing Drug Delivery You've got...

Continue Reading
Greenberg Traurig Eyes Accolades in Middle East Awards

Updated Category News Views 3

Greenberg Traurig Aims for Middle Eastern Legal Dominance Ah, the legal world, where firms jostle like bulls in a market for the prestige of an award—it's not just about the courtroom victories, but also about snatching the right titles at glossy ceremonies. On the docket this time: Greenberg Traurig has its sights set on several prime accolades at the Law Middle East...

Continue Reading
California Contractors Honored for Safety Commitment

Updated Category News Views 9

Commitment to Safety in the Construction Industry When it comes to construction, safety isn’t an afterthought—it’s woven into the very fabric of every project. The 39th Annual Construction Safety Excellence Awards by the Associated General Contractors of California (AGC of California) pits a spotlight on those embodying this ethos. Industry Leaders in Safety Held on...

Continue Reading
Dimethylaminopropylamine Market Eyes $732M by 2035

Updated Category News Views 0

Surfactants and Epoxy Fuel Dimethylaminopropylamine Demand Hot off the presses, folks! Dimethylaminopropylamine, or DMAPA if you're into acronyms, is gearing up for a steady climb to a $731.9 million market value by the year 2035. That's quite the leap from the $452.6 million we saw back in 2025. According to Credence Research's latest estimates, this amine is hitching...

Continue Reading

Top 5 Most Recently Viewed Articles

Bradley J. Ehrman's Strategic Purchase of Dorchester Minerals Shares

Updated Category News Views 109

Bradley J. Ehrman Demonstrates Confidence in Dorchester Minerals Recently, the financial landscape witnessed an intriguing move as Bradley J. Ehrman, the Chief Executive Officer of Dorchester Minerals (NASDAQ: DMLP), opted to invest a substantial $100,008 in company shares. This significant insider purchase, reported through recent SEC filings, underscores his confidence...

Continue Reading
Datasea Anticipates $90 Million Revenue Growth in Fiscal 2025

Updated Category News Views 92

Datasea Projects Significant Revenue Increase for Fiscal 2025 Datasea Inc. (NASDAQ: DTSS) has announced its expectations for a remarkable revenue surge, projecting around $90 million for the fiscal year ending in June 2025. This anticipated figure represents a significant year-over-year increase of 275%, a leap from the previous year's revenue of $24 million. Strong...

Continue Reading
Univera Unveils Innovative RegeniCARE Gift Set for Wellness

Updated Category News Views 233

Univera Launches the RegeniCARE Gift Set for Convenient Wellness Univera has officially released its first RegeniCARE Gift Set, a unique offering designed to enhance joint care and overall wellness. This set is perfect for those seeking an effective and portable health solution. A Comprehensive Solution for Joint Care The RegeniCARE Gift Set includes a premium canister of...

Continue Reading
Apple's Tim Cook Strengthens Ties with China's IT Sector

Updated Category News Views 176

Tim Cook's Commitment to China's Tech Future Tim Cook, the CEO of Apple Inc. (NASDAQ: AAPL), has recently emphasized the importance of the Chinese market through his meetings with key government officials. His latest engagement was with Jin Zhuanglong, the Minister for Industry and Information Technology. This meeting reflects Apple's ongoing strategy to enhance its user...

Continue Reading
Clearmind Medicine Expands Clinical Trials with Key Partnership

Updated Category News Views 121

Clearmind Medicine Expands Clinical Trials with Key Partnership Clearmind Medicine Inc. (NASDAQ: CMND), a forward-thinking biotech company, has taken a significant step in its mission to tackle Alcohol Use Disorder (AUD) through the expansion of its clinical trial network. The company has recently partnered with the Tel Aviv Sourasky Medical Center, adding this esteemed...

Continue Reading